GLANDGland Pharma Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-07-20 (delayed ~30 min in market hours)
₹2,459.10
▲ 0.41%Strong
Price & Volume
Loading chart…
Key Ratios
Market Cap (₹ cr)40,565.20
P/E39.54
P/B3.91
PEG0.41
ROE %10.53
ROCE %11.30
Debt / Equity0.03
EPS62.20
Revenue Growth %22.30
Profit Growth %96.40
Dividend Yield %0.73
Promoter Holding %51.77
FII Holding %34.35
DII Holding %—
Beta0.49
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
| Pullback to 21-EMA | LONG | 80% | ₹2,459.10 | ₹2,379.40 | ₹2,616.20 | 1.97 |
BUYConviction 84%
Why buy
- • Revenue growth: 22.3% YoY
- • Profit growth: 96.4% YoY
- • Debt/Equity: 0.03
- • RSI: 57
- • Price vs EMA21: above
- • Price vs SMA50: above
- • Pullback to 21-EMA signal (setup quality 80%)
Bull case
- • Revenue growth: 22.3% YoY
- • Profit growth: 96.4% YoY
- • Debt/Equity: 0.03
- • RSI: 57
Bear case
- • ROE: 10.5%
- • MACD: bearish
- • Volume: 0.5x 20-day average
- • Volume trend: 0.8x baseline
Key risks
- • ROE: 10.5%
- • MACD: bearish
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Entry (CMP)
₹2,459.10
Stop Loss
₹2,259.84
risk 8.1%
Target 1 (1.5R)
₹2,757.99
+12.2%
Target 2 (3R)
₹3,056.88
+24.3%
Support (20d)
₹2,185.00
Resistance (52w)
₹2,573.50
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹199.26/share
ATR (volatility)
₹79.70
avg daily range
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹79.70). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.
Score Breakdown
Fundamental
74
Technical
67
Momentum
88
Risk (safety)
74